IOL Chemicals and Pharmaceuticals Receives Approval to Strike Off Subsidiary
IOL Chemicals and Pharmaceuticals Limited announced that the Registrar of Companies has approved the application to strike off IOL Life Sciences Limited, a wholly-owned subsidiary, from the Register of Companies. The approval was conveyed via Notice No. STK-7/001115/2026 dated April 1, 2026.As of March 31, 2025, IOL Life Sciences Limited contributed revenue of nil, representing 0% of the company's total revenue, and a net worth of 638,838, representing 0% of the company’s net worth. The strike-off is not expected to have a material impact on the financials or operations of IOL Chemicals and Pharmaceuticals Limited.
| S.No. | Requirement of Disclosure | Details |
|---|---|---|
| a | The amount and percentage of the turnover or revenue or income and net worth contributed by such unit or division or undertaking or subsidiary or associate company of the listed entity during the last financial year. | As on March 31, 2025: Revenue from operations (in Rs.): Nil Percentage:0% Net Worth (in Rs.): 638838/- Percentage:0% |
| b | Date on which the agreement for sale has been entered into; | Not Applicable IOL Life Sciences Limited, a wholly owned subsidiary of the Company had made an applicationon 27 TH January 2026 for striking off its name from the records of Registrar of Companies. The Registrar of Companies, Ministry of Corporate Affairs, has approved the application of striking off the name of the wholly owned subsidiary vide Notice No.STK-7/001115/2026dated1 st April 2026. |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.